ANNOUNCEMENT OF AVAILABILITY: INTERAGENCY REGISTRY OF MECHANICAL CIRCULATORY
SUPPORT FOR END-STAGE HEART FAILURE RFP-NHLBI-HV-05-08
RELEASE DATE: May 13, 2004
NOTICE: NOT-HL-04-112
National Heart, Lung, and Blood Institute (NHLBI)
(http://www.nhlbi.nih.gov/)
The goal of the proposed program is to establish a data and clinical coordinating
center (DCC) to manage a registry of patients receiving a mechanical circulatory
support device (MCSD) to treat heart failure. The registry will collect and
analyze clinical and laboratory data and tissue samples from patients who are
receiving MCSDs as destination therapy for end-stage heart failure at 60 to 70
participating hospitals. It is anticipated that the registry will collect data,
blood and tissue samples from approximately 2,000 new patients per year for a
period of five years.
The program will be performed in two phases. In Phase I (6 months), the DCC will
develop a protocol, manual of operations, study forms and formats for web-based
collection, and methods to insure accuracy of data submitted to the registry. The
manual of operations will include policies for publication, conflict of interest,
privacy issues, data security and use of stored data. During this phase, criteria
to certify hospitals to participate in the program will be established and
training plans will be developed for registry personnel. In Phase II (4 years and
6 months), the DCC will provide overall coordination of the program.
Participating hospitals will be trained, certified and required to maintain
established performance standards. Eligible patients will be consented, enrolled
and their data and samples collected. The DCC will monitor study progress and
assure data accuracy. Each participating hospital will be site visited during
this phase and additional site visits may be performed as needed. Also, during
this phase, the DCC will consider revision to the protocol and manual of
operations as appropriate in response to new devices or changes in knowledge and
treatment of heart failure patients. In performing the work of the registry, the
DCC will work closely with the following committees:
o Steering Committee - This committee will define enrollment, establish
eligibility for detailed follow-up, determine a target number of patients for each
device, finalize the protocol and provide scientific direction to the registry at
an operational level. The Steering Committee will consist of the Principal
Investigator of the DCC, the Steering Committee Chairperson, staff members from
the Food and Drug Administration (FDA) and Centers for Medicare and Medicaid
Services (CMS), and representatives from the selected participating hospitals.
o Operations Committee - This is an executive committee of the Steering Committee
with oversight and authority for the day to day operations of the study. The
Operations Committee will include the Principal Investigator of the DCC, the
Steering Committee Chairperson, and representatives from the FDA and CMS.
o Data and Safety Monitoring Board (DSMB) - This Board will be appointed by the
NHLBI and will be established to monitor overall progress, data outcomes and
patient safety. The DSMB will periodically evaluate procedures, findings, and
adverse events and advise the NHLBI when changes should be made.
This announcement is not a request for proposals (RFP). It is anticipated that
RFP-NHLBI-HV-05-08 for this program will be available on or about May 19, 2004
through the NHLBI Website at: http://www.nhlbi.nih.gov/funding/inits/index.htm#rfp
and posted at: http://www.fedbizopps.gov. Proposals will be due to be received on
August 4, 2004. This announcement does not commit the Government to award a
contract.
Contracting Office Address:
National Institutes of Health
National Heart, Lung, and Blood Institute
Contracts Operations Branch
Rockledge Building (RKL2), Room 6224
6701 ROCKLEDGE DR, MSC-7902
BETHESDA, MD 20892 -7902
Point of Contact:
Douglas Frye, Contracting Officer, Phone 301-435-0330, Email [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
Department of Health and Human Services (HHS) |
|
||||
|
NIH... Turning Discovery Into Health® |
||||||